IT1401494B1 - INHALATION FORMULATIONS IN THE FORM OF SOLUTIONS OR DRIED POWDERS, FOR THE REMOVAL OF MUCOSE SECRECTIONS FROM THE RESPIRATORY SYSTEM - Google Patents

INHALATION FORMULATIONS IN THE FORM OF SOLUTIONS OR DRIED POWDERS, FOR THE REMOVAL OF MUCOSE SECRECTIONS FROM THE RESPIRATORY SYSTEM

Info

Publication number
IT1401494B1
IT1401494B1 ITMI2010A001440A ITMI20101440A IT1401494B1 IT 1401494 B1 IT1401494 B1 IT 1401494B1 IT MI2010A001440 A ITMI2010A001440 A IT MI2010A001440A IT MI20101440 A ITMI20101440 A IT MI20101440A IT 1401494 B1 IT1401494 B1 IT 1401494B1
Authority
IT
Italy
Prior art keywords
secrections
mucose
removal
solutions
respiratory system
Prior art date
Application number
ITMI2010A001440A
Other languages
Italian (it)
Inventor
Patrizia Pattini
Original Assignee
Eupharma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eupharma Srl filed Critical Eupharma Srl
Priority to ITMI2010A001440A priority Critical patent/IT1401494B1/en
Priority to DE202011103553U priority patent/DE202011103553U1/en
Priority to FR1156797A priority patent/FR2963235A1/en
Publication of ITMI20101440A1 publication Critical patent/ITMI20101440A1/en
Application granted granted Critical
Publication of IT1401494B1 publication Critical patent/IT1401494B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
ITMI2010A001440A 2010-07-30 2010-07-30 INHALATION FORMULATIONS IN THE FORM OF SOLUTIONS OR DRIED POWDERS, FOR THE REMOVAL OF MUCOSE SECRECTIONS FROM THE RESPIRATORY SYSTEM IT1401494B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI2010A001440A IT1401494B1 (en) 2010-07-30 2010-07-30 INHALATION FORMULATIONS IN THE FORM OF SOLUTIONS OR DRIED POWDERS, FOR THE REMOVAL OF MUCOSE SECRECTIONS FROM THE RESPIRATORY SYSTEM
DE202011103553U DE202011103553U1 (en) 2010-07-30 2011-07-21 Inhalation preparations in the form of solutions or dry powder for the removal of mucous secretions from the respiratory system
FR1156797A FR2963235A1 (en) 2010-07-30 2011-07-26 Inhalation administration in form of e.g. hypertonic solutions, useful for the removal of bronchial secretions, comprises an osmolar-acting agent e.g. sodium chloride, and hyaluronic acid, suspect preservatives or pharmaceutical excipients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2010A001440A IT1401494B1 (en) 2010-07-30 2010-07-30 INHALATION FORMULATIONS IN THE FORM OF SOLUTIONS OR DRIED POWDERS, FOR THE REMOVAL OF MUCOSE SECRECTIONS FROM THE RESPIRATORY SYSTEM

Publications (2)

Publication Number Publication Date
ITMI20101440A1 ITMI20101440A1 (en) 2012-01-31
IT1401494B1 true IT1401494B1 (en) 2013-07-26

Family

ID=43706436

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2010A001440A IT1401494B1 (en) 2010-07-30 2010-07-30 INHALATION FORMULATIONS IN THE FORM OF SOLUTIONS OR DRIED POWDERS, FOR THE REMOVAL OF MUCOSE SECRECTIONS FROM THE RESPIRATORY SYSTEM

Country Status (3)

Country Link
DE (1) DE202011103553U1 (en)
FR (1) FR2963235A1 (en)
IT (1) IT1401494B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2437690B1 (en) * 2012-07-10 2014-10-24 Chiesi Farmaceutici S.P.A. Inhalation formulations in the form of solutions or dry powders, for the removal of mucous secretions from the respiratory system
FR3019465B1 (en) 2014-04-02 2017-06-23 Horus Pharma HYPEROSMOLAR COMPOSITION OF HYALURONIC ACID AND USE THEREOF FOR THE TREATMENT OF CORNEAL EDEMA
IT202000021361A1 (en) * 2020-09-09 2022-03-09 Sofar Spa HYALURONIC ACID OR A SALT THEREOF FOR INHALATION USE IN THE TREATMENT OF RESPIRATORY DISEASES, AND AN INHALER DEVICE CONTAINING THE SAME

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1292314A2 (en) * 2000-05-23 2003-03-19 The Trustees of Columbia University in the City of New York Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of glycosaminoglycans
AU2002315330A1 (en) * 2001-06-15 2003-01-02 Exhale Therapeutics, Inc. Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acid
DE102004002001A1 (en) * 2004-01-14 2005-08-11 Reinmüller, Johannes, Dr.med. Agent for the treatment of inflammatory diseases
ITMI20060742A1 (en) * 2006-04-13 2007-10-14 Patrizia Pattini ANTIBACTERIAL COMPOSITIONS FOR TREATMENT OF INFECTION OF HIGH AND LOW AIRCRAFT

Also Published As

Publication number Publication date
DE202011103553U1 (en) 2011-11-10
FR2963235A1 (en) 2012-02-03
ITMI20101440A1 (en) 2012-01-31

Similar Documents

Publication Publication Date Title
HK1254470A1 (en) 3' equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals
SMT201400048B (en) 1-substituted beta-nucleoside prodrugs for antiviral treatment
CA2865972C (en) Inhalable dry powders
IL221160A (en) 1,2,4-triazine-3-amine derivatives, process for the preparation thereof and use thereof in the preparation of medicaments
SMT201500289B (en) SYSTEMS FOR THE ASPIRATION OF SMALL GAUGE ELEMENTS
EP2568954A4 (en) Fragrant formulations, methods of manufacture thereof and articles comprising the same
IL212573A (en) Aryl methyl benzoquinazolinone compounds, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
BRPI1011813A2 (en) "inhaler"
FR2966804B1 (en) AERODYNE COMPRISING MOTORIZED LANDING TRAINS
PL2768937T3 (en) Formulations, their use as or for the manufacture of dishwashing agents and their manufacture
ZA201101477B (en) Co-crystals and pharmaceutical formulations comprising the same
IT1402907B1 (en) TOPIC COMPOSITIONS TO MAINTAIN OR RESTORE THE INTEGRITY OF THE MUCOSE.
EP2627317A4 (en) Aggregate nanoparticulate medicament formulations, manufacture and use thereof
SMT201400076B (en) Pharmaceutical formulations against the improper use of medicines
IT1402018B1 (en) FORMULATIONS FOR THE TREATMENT OF THE AFFECTIONS OF THE FIRST RESPIRATORY ROUTES.
SI2739615T1 (en) Phenyl-3-aza-bicyclo(3.1.0)hex-3-yl-methanones and the use thereof as medicament
HK1144553A1 (en) Use of an acetylsalicylic acid salt for the treatment of viral infections
SMT201600190B (en) USE OF STREPTOCOCCUS SALIVARIUS IN THE TREATMENT OF CHRONIC INFECTIONS OF THE RESPIRATORY SYSTEM
HK1203390A1 (en) Polyinosinic-polycytidylic acid (poly(1:c)) formulations for the treatment of upper respiratory tract infections -((i:c))
EP2594283A4 (en) Aprotinin-based aerosol preparation for the treatment of viral respiratory infections
IT1395917B1 (en) EQUIPMENT AND METHOD FOR POLISHING THE CAVITIES OF MECHANICAL COMPONENTS.
IT1401494B1 (en) INHALATION FORMULATIONS IN THE FORM OF SOLUTIONS OR DRIED POWDERS, FOR THE REMOVAL OF MUCOSE SECRECTIONS FROM THE RESPIRATORY SYSTEM
IT1405996B1 (en) PROCEDURE FOR THE PREPARATION OF 2,5-DIAMINOTOLUOL
HK1215393A1 (en) 1,3-dihydroimidazole-2-thione derivatives for use in the treatment of pulmonary arterial hypertension and lung injury 13--2-
IT1401698B1 (en) CATALYST FOR THE DECOMPOSITION OF DANGEROUS PROSTOSIS.